Oxford BioDynamics Ownership

OXBOF Stock  USD 0.01  0.01  52.38%   
Oxford BioDynamics owns a total of 146.71 Million outstanding shares. Over half of Oxford BioDynamics' outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Oxford BioDynamics in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Oxford BioDynamics, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oxford BioDynamics Plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Oxford Pink Sheet Ownership Analysis

About 31.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.19. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Oxford BioDynamics Plc recorded a loss per share of 0.09. The entity had not issued any dividends in recent years. Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom. Oxford Biodynamics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 44 people.The quote for Oxford BioDynamics Plc is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Oxford BioDynamics Plc contact the company at 44 1865 518 910 or learn more at https://www.oxfordbiodynamics.com.

Currently Active Assets on Macroaxis

Other Information on Investing in Oxford Pink Sheet

Oxford BioDynamics financial ratios help investors to determine whether Oxford Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oxford with respect to the benefits of owning Oxford BioDynamics security.